Click here for Analysts' Upgrades, Downgrades.

Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK ( TheStreet) -- Alimera Sciences ( ALIM) price target cut at Citi to $12 from $15 after FDA did not approve lluvien NDA. Maintain Buy rating.

Google ( GOOG) target increased at Kaufman to $690. Company should benefit from strong domestic online holiday sales.

Rovi ( ROVI) estimates, target raised at Wedbush. Shares of ROVI now seen reaching $59, according to Wedbush Securities. Estimates also increased, to match the company's new guidance, following the SNIC acquisition.

Time Warner Cable ( TWC) target boosted at Argus to $75. Company is leveraged to benefit from a recovery in the economy. Buy rating.
This article was written by a staff member of TheStreet.

If you liked this article you might like

Alimera (ALIM) Is Today's Strong On High Volume Stock

Weak On High Volume: Alimera (ALIM)

Insider Trading Alert - VLGEA, LLTC And ALIM Traded By Insiders

5 Stocks Insiders Love Right Now

5 Stocks Under $10 Set to Soar